A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed
Publication
, Conference
Halabi, S; Lin, C-Y; Small, EJ; Armstrong, AJ; Kaplan, EB; Petrylak, DP; Sternberg, CN; Shen, L; Oudard, S; De Bono, JS; Sartor, AO
Published in: JOURNAL OF CLINICAL ONCOLOGY
February 20, 2013
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
February 20, 2013
Volume
31
Issue
6
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
Genitourinary Cancers Symposium of the Conquer-Cancer-Foundation of American-Society-of-Clinical-Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Halabi, S., Lin, C.-Y., Small, E. J., Armstrong, A. J., Kaplan, E. B., Petrylak, D. P., … Sartor, A. O. (2013). A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 31). Orlando, FL: AMER SOC CLINICAL ONCOLOGY. https://doi.org/10.1200/jco.2013.31.6_suppl.24
Halabi, Susan, Chen-Yen Lin, Eric Jay Small, Andrew J. Armstrong, Ellen B. Kaplan, Daniel Peter Petrylak, Cora N. Sternberg, et al. “A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013. https://doi.org/10.1200/jco.2013.31.6_suppl.24.
Halabi S, Lin C-Y, Small EJ, Armstrong AJ, Kaplan EB, Petrylak DP, et al. A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.
Halabi, Susan, et al. “A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed.” JOURNAL OF CLINICAL ONCOLOGY, vol. 31, no. 6, AMER SOC CLINICAL ONCOLOGY, 2013. Wos, doi:10.1200/jco.2013.31.6_suppl.24.
Halabi S, Lin C-Y, Small EJ, Armstrong AJ, Kaplan EB, Petrylak DP, Sternberg CN, Shen L, Oudard S, De Bono JS, Sartor AO. A model for predicting overall survival in men with metastatic castrate-resistant prostate cancer (CRPC) for whom first-line chemotherapy failed. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.
Published In
JOURNAL OF CLINICAL ONCOLOGY
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
February 20, 2013
Volume
31
Issue
6
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
Genitourinary Cancers Symposium of the Conquer-Cancer-Foundation of American-Society-of-Clinical-Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences